Observational studyMedicine2020

Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience.

Sherief Abd-Elsalam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.